[1] Botterel F, Foulet F, Legrand P, et al. Yeast contamination of kidney, liver and cardiac preservation solutions before graft: need for standardisation of microbial evaluation. J Hosp Infect, 2010,76: 52-55.
[2] Chiereghin A, Petrisli E, Ravaioli M, et al. Infectious agents after liver transplant: etiology, timeline and patients' cell-mediated immunity responses. Med Microbiol Immunol, 2017,206: 63-71.
[3] Abdelhamid NM, Chen YC, Wang YC, et al. Pre-transplantation immune cell distribution and early post-transplant fungal infection are the main risk factors of liver transplantation recipients in lower model of end-stage liver disease. Transplant Proc, 2017,49: 92-97.
[4] Shi SH, Lu AW, Shen Y, et al. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation. Chin Med J (Engl), 2008,121: 625-630.
[5] Saliba F, Delvart V, Ichai P, et al. Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era. Clin Transplant, 2013,27: E454-E461.
[6] Liu X, Ling Z, Li L, et al. Invasive fungal infections in liver transplantation. Int J Infect Dis, 2011,15: e298-e304.
[7] Paya CV. Prevention of fungal and hepatitis virus infections in liver transplantation. Clin Infect Dis, 2001,33 Suppl 1:S47-S52.
[8] De Luca M, Green M, Symmonds J, et al. Invasive candidiasis in liver transplant patients: Incidence and risk factors in a pediatric cohort. Pediatr Transplant, 2016,20: 235-240.
[9] Pacholczyk M, Lagiewska B, Lisik W, et al. Invasive fungal infections following liver transplantation - risk factors, incidence and outcome. Ann Transplant, 2011,16: 14-16.
[10] 覃莉, 罗羽鸥, 罗艳丽. 成人间活体肝移植术后受体真菌感染的易感因素分析. 华西医学, 2016,31:679-682.
[11] Sonzogni A, Colledan M, Aluffi A, et al. Lethal infection by Candida (Torulopsis) incospicua complicating orthotopic liver transplantation. Transplant Proc, 2004,36: 2778-2781.
[12] Kusne S, Torre-Cisneros J, Manez R, et al. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis, 1992,166: 1379-1383.
[13] Park YS, Seo JB, Lee YK, et al. Radiological and clinical findings of pulmonary aspergillosis following solid organ transplant. Clin Radiol, 2008,63: 673-680.
[14] Pazos C, Ponton J, Del PA. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol, 2005,43: 299-305.
[15] Liu X, Ling Z, Li L, et al. Invasive fungal infections in liver transplantation. Int J Infect Dis, 2011,15: e298-e304.
[16] Perfect JR. Is there an emerging need for new antifungals. Expert Opin Emerg Drugs, 2016,21: 129-131.
[17] 卫蓓文, 季育华, 胡炯. 氟康唑与伊曲康唑预防移植术后侵袭性真菌感染的系统评价. 检验医学, 2010,10:801-806.
[18] 孟帅, 孙丽莹, 朱立勤, 等. 伏立康唑与氟康唑治疗肝移植患者术后真菌感染的安全性比较. 山东医药, 2015,13:61-62.
[19] Andes D. In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis. Antimicrob Agents Chemother, 2003,47: 1179-1186.
[20] 唐蕾, 钱爱民. 抗深部真菌药临床应用研究进展. 中国药房, 2012,42:4010-4013.
[21] Chen YC, Huang TS, Wang YC, et al. Effect of prophylactic antifungal protocols on the prognosis of liver transplantation: a propensity score matching and multistate model approach. Biomed Res Int, 2016,2016:6212503.
[22] Evans JD, Morris PJ, Knight SR. Antifungal prophylaxis in liver transplantation: a systematic review and network meta-analysis. Am J Transplant, 2014,14 :2765-2776. |
